Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Crosstalk between FSH and relaxin at the end of the proliferative stage of rat Sertoli cells

Full text
Author(s):
Nascimento, Aline R. ; Macheroni, Carla ; Lucas, Thais F. G. ; Porto, Catarina S. ; Lazari, Maria F. M.
Total Authors: 5
Document type: Journal article
Source: Reproduction; v. 152, n. 6, p. 613-628, DEC 2016.
Web of Science Citations: 5
Abstract

Follicle-stimulating hormone (FSH) stimulates the proliferation of immature Sertoli cells through the activation of PI3K/AKT/mTORC1 and MEK/ERK1/2 pathways. Mature Sertoli cells stop proliferating and respond to FSH by stimulating cAMP production. To gain insight into possible mechanisms involved in this switch as well as the impact of paracrine factors that stimulate cell proliferation, we analyzed the effects of FSH and relaxin on intracellular signaling pathways involved with proliferation and differentiation in Sertoli cells from 15-day-old rats, which are close to the transition between the two stages. FSH stimulated H-3-thymidine incorporation and cyclin D1 expression, changes associated with proliferation. In contrast, FSH inhibited AKT and ERK1/2 phosphorylation, activated cAMP production and induced changes in several cell cycle genes that were compatible with differentiation. Relaxin also stimulated 3H-thymidine incorporation but increased phosphorylation of ERK1/2 and AKT. When both hormones were added simultaneously, relaxin attenuated FSH-mediated inhibition of ERK1/2 and AKT phosphorylation and FSH-mediated activation of cAMP production. FSH but not relaxin increased CREB phosphorylation, and relaxin but not FSH shifted NF-kappa B expression from the cytoplasm to the nucleus. Relaxin did not inhibit the effects of FSH on inhibin alpha and Bcl2 expression. We propose that at this time of Sertoli cell development, FSH starts to direct cells to differentiation through activation of cAMP/CREB and inhibition of ERK1/2 and AKT pathways. Relaxin counteracts FSH signaling through the inhibition of cAMP and activation of ERK1/2, AKT and NF-kappa B, but does not block the differentiation process triggered by FSH. (AU)

FAPESP's process: 10/10274-2 - Analysis of the role of relaxin in early and late stages of spermatogenesis, using co-cultures of Sertoli and germ cells
Grantee:Maria de Fátima Magalhães Lazari
Support Opportunities: Regular Research Grants
FAPESP's process: 14/05028-3 - Relaxin signaling in testis: investigation of the presence of isoforms of the RXFP1 receptor, NOS/NO signaling, and the possible participation of the glucocorticoid receptor
Grantee:Carla Macheroni Lima
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 14/08563-7 - Exploring possible new receptors and signaling pathways that may contribute to the modulatory effect of relaxin on proliferation and differentiation of Sertoli cells
Grantee:Maria de Fátima Magalhães Lazari
Support Opportunities: Regular Research Grants
FAPESP's process: 11/14262-1 - Role of relaxin in different stages of Sertoli cell development: characterization of the intracellular signaling, effects on gene and protein expression and modulation by FSH
Grantee:Aline Rosa do Nascimento
Support Opportunities: Scholarships in Brazil - Doctorate